| Bioactivity | RPR103611, the betulinic acid derivative, is a potent HIV-1 entry inhibitor with IC50s of 80, 0.27, and 0.17 for CCR5-tropic virus YU2, CXCR4-tropic virus NL4-3 and dual tropic virus 89.6, respectively[1]. |
| Name | RPR103611 |
| CAS | 150840-75-8 |
| Formula | C46H78N2O6 |
| Molar Mass | 755.12 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Reon Takeuchi, et al. Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds. Bioorg Med Chem Lett. 2022 Aug 1;69:128768. |
RPR103611
CAS: 150840-75-8 F: C46H78N2O6 W: 755.12
RPR103611, the betulinic acid derivative, is a potent HIV-1 entry inhibitor with IC50s of 80, 0.27, and 0.17 for CCR5-tr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.